Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion type Assertion NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_head.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion description "[Both EA and Mox treatments are effective at ameliorating gastrointestinal symptoms by reducing SP and VIP expression in the colonic mucosa of IBS patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_provenance.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion evidence source_evidence_literature NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_provenance.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion SIO_000772 26427109 NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_provenance.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion wasDerivedFrom befree-2016 NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_provenance.
- NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_assertion wasGeneratedBy ECO_0000203 NP1294607.RAfBgvPmtgQe1xoTfxTEMqj3-GnFIRpDLXA6mCYlQ0Sj4130_provenance.